Table 2.
Characteristics of Fiebig I subjects (n=25) |
4thG stage 1 |
4thG stage 2 |
P value |
---|---|---|---|
(n=18) | (n=7) | ||
HIV RNA, log10copies/ml |
4.6 |
5.7 |
0.005 |
HIV DNA, copies/106 PBMC |
7 |
312 |
0.002 |
Duration since history of HIV exposure, days | 12.5 | 17 | 0.06 |
Abbreviation: PBMC peripheral blood mononuclear cells.